Xenon Market Size to Hit USD 228.96 Million Forecast by 2028; Increasing Number of Space Missions and Satellite Launches to Propel Growth, Says Fortune Business Insights™
May 05, 2021 08:00 ET
|
Fortune Business Insights
Pune, India, May 05, 2021 (GLOBE NEWSWIRE) -- The global xenon market size is projected to reach USD 228.96 million by 2028, exhibiting a CAGR of 1.8% during the forecast period. Fortune Business...
Automotive Lighting Market Growth Sturdy at 3.3% CAGR to Outstrip $40.41 Billion by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
April 22, 2021 11:30 ET
|
The Insight Partners
PUNE, India, April 22, 2021 (GLOBE NEWSWIRE) -- Automotive Lighting Market: Key InsightsAccording to our new research study on “Automotive Lighting Market to 2027 – Global Analysis and Forecast – by...
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
October 30, 2020 09:00 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will...
Xenon Market to Touch USD 226.7 Million by 2027; Replacement of Conventional Lighting Systems with LED Units to Create Huge Demand for Xenon: Fortune Business Insights™
October 16, 2020 04:00 ET
|
Fortune Business Insights
Pune, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The global xenon market size is projected to reach USD 226.7 million by 2027, exhibiting a CAGR of 1.7% during the forecast period. High adoption of xenon gas...
Automotive Lighting Market to surpass $40bn by 2024: Global Market Insights, Inc.
October 01, 2018 05:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Global Automotive Lighting Market is expected to cross USD 40 billion by 2024; according to a new research report by Global Market...
Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder
June 14, 2017 13:34 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...
Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases
June 12, 2017 18:57 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...
NPSF Patient Safety Coalition Welcomes Xenex
February 25, 2015 09:38 ET
|
The National Patient Safety Foundation
BOSTON, Mass., Feb. 25, 2015 (GLOBE NEWSWIRE) -- The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, recently welcomed Xenex Disinfection Services as a member...